Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients

NCT06605885 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06605885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06605885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
November 14, 2024
Completion date
September 30, 2026
Enrollment
202 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

asthma